| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Software | 13 | 2023 | 671 | 3.840 |
Why?
|
| Computational Biology | 14 | 2023 | 793 | 3.710 |
Why?
|
| Transcriptome | 15 | 2024 | 901 | 3.100 |
Why?
|
| Sequence Analysis, RNA | 12 | 2024 | 369 | 2.650 |
Why?
|
| Gene Expression Profiling | 20 | 2023 | 1674 | 2.640 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 14 | 2024 | 295 | 1.970 |
Why?
|
| Gene Regulatory Networks | 9 | 2023 | 351 | 1.850 |
Why?
|
| Polyadenylation | 4 | 2024 | 54 | 1.810 |
Why?
|
| Algorithms | 9 | 2024 | 1572 | 1.390 |
Why?
|
| Single-Cell Analysis | 3 | 2023 | 259 | 1.350 |
Why?
|
| Models, Statistical | 3 | 2023 | 445 | 1.320 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2018 | 864 | 1.270 |
Why?
|
| Alzheimer Disease | 10 | 2023 | 753 | 1.250 |
Why?
|
| Statistics as Topic | 2 | 2017 | 244 | 1.080 |
Why?
|
| tau Proteins | 7 | 2023 | 188 | 0.980 |
Why?
|
| Rett Syndrome | 8 | 2024 | 277 | 0.970 |
Why?
|
| Databases, Genetic | 6 | 2019 | 469 | 0.960 |
Why?
|
| Markov Chains | 2 | 2016 | 79 | 0.960 |
Why?
|
| PubMed | 1 | 2023 | 21 | 0.890 |
Why?
|
| Gene Expression Regulation | 8 | 2024 | 2538 | 0.810 |
Why?
|
| Disease Susceptibility | 3 | 2022 | 297 | 0.800 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2015 | 999 | 0.790 |
Why?
|
| Disease Models, Animal | 20 | 2023 | 4274 | 0.790 |
Why?
|
| Neural Stem Cells | 2 | 2020 | 126 | 0.760 |
Why?
|
| Poly A | 1 | 2021 | 60 | 0.760 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2022 | 458 | 0.760 |
Why?
|
| Clustered Regularly Interspaced Short Palindromic Repeats | 2 | 2019 | 64 | 0.750 |
Why?
|
| Mental Retardation, X-Linked | 4 | 2024 | 102 | 0.730 |
Why?
|
| Herpesvirus 7, Human | 1 | 2019 | 3 | 0.700 |
Why?
|
| Animals | 59 | 2024 | 33662 | 0.680 |
Why?
|
| Roseolovirus Infections | 1 | 2019 | 33 | 0.670 |
Why?
|
| Medicine | 2 | 2017 | 97 | 0.670 |
Why?
|
| Genomics | 5 | 2019 | 1473 | 0.660 |
Why?
|
| Herpesvirus 6, Human | 1 | 2019 | 59 | 0.660 |
Why?
|
| Mice | 41 | 2024 | 17487 | 0.660 |
Why?
|
| Brain | 14 | 2023 | 2944 | 0.650 |
Why?
|
| Neurons | 10 | 2024 | 1916 | 0.640 |
Why?
|
| Base Pairing | 1 | 2018 | 43 | 0.620 |
Why?
|
| MicroRNAs | 5 | 2020 | 835 | 0.600 |
Why?
|
| RNA Splicing | 5 | 2019 | 224 | 0.600 |
Why?
|
| RNA | 3 | 2024 | 578 | 0.590 |
Why?
|
| Spinocerebellar Ataxias | 4 | 2022 | 254 | 0.590 |
Why?
|
| Nerve Tissue Proteins | 7 | 2019 | 1107 | 0.590 |
Why?
|
| Biology | 1 | 2017 | 28 | 0.580 |
Why?
|
| CRISPR-Cas Systems | 2 | 2019 | 246 | 0.570 |
Why?
|
| Cell Differentiation | 5 | 2020 | 1923 | 0.560 |
Why?
|
| Internationality | 1 | 2017 | 128 | 0.550 |
Why?
|
| Nervous System Diseases | 2 | 2024 | 372 | 0.550 |
Why?
|
| Congresses as Topic | 1 | 2017 | 163 | 0.540 |
Why?
|
| Ataxin-1 | 5 | 2022 | 168 | 0.540 |
Why?
|
| Oligonucleotides, Antisense | 3 | 2024 | 74 | 0.540 |
Why?
|
| Sequence Analysis, DNA | 4 | 2019 | 1758 | 0.540 |
Why?
|
| Humans | 71 | 2024 | 121732 | 0.520 |
Why?
|
| Alternative Splicing | 1 | 2017 | 346 | 0.500 |
Why?
|
| Linear Models | 1 | 2017 | 655 | 0.490 |
Why?
|
| Drosophila melanogaster | 8 | 2023 | 736 | 0.480 |
Why?
|
| Genome, Human | 4 | 2019 | 1251 | 0.470 |
Why?
|
| Programming, Linear | 1 | 2014 | 4 | 0.460 |
Why?
|
| Reproducibility of Results | 8 | 2024 | 2795 | 0.460 |
Why?
|
| Huntington Disease | 3 | 2021 | 140 | 0.440 |
Why?
|
| Breast Neoplasms | 5 | 2021 | 2486 | 0.430 |
Why?
|
| Ovarian Neoplasms | 2 | 2014 | 415 | 0.430 |
Why?
|
| Tauopathies | 3 | 2023 | 56 | 0.410 |
Why?
|
| RNA Interference | 4 | 2019 | 495 | 0.410 |
Why?
|
| 3' Untranslated Regions | 3 | 2021 | 166 | 0.380 |
Why?
|
| DNA Copy Number Variations | 7 | 2024 | 943 | 0.370 |
Why?
|
| Cerebellum | 5 | 2022 | 410 | 0.350 |
Why?
|
| Phenotype | 7 | 2024 | 4198 | 0.350 |
Why?
|
| ras Proteins | 2 | 2018 | 136 | 0.340 |
Why?
|
| Autism Spectrum Disorder | 3 | 2020 | 373 | 0.330 |
Why?
|
| GABAergic Neurons | 2 | 2020 | 54 | 0.330 |
Why?
|
| Repressor Proteins | 3 | 2019 | 810 | 0.330 |
Why?
|
| Tumor Microenvironment | 3 | 2022 | 552 | 0.320 |
Why?
|
| Synapses | 4 | 2022 | 440 | 0.320 |
Why?
|
| DNA Probes | 1 | 2008 | 125 | 0.320 |
Why?
|
| Oligonucleotides | 1 | 2008 | 88 | 0.310 |
Why?
|
| DNA-Binding Proteins | 5 | 2021 | 2038 | 0.310 |
Why?
|
| Neuronal Plasticity | 3 | 2020 | 272 | 0.310 |
Why?
|
| Drosophila Proteins | 5 | 2021 | 708 | 0.310 |
Why?
|
| Databases, Factual | 4 | 2023 | 1139 | 0.300 |
Why?
|
| Computer Simulation | 3 | 2017 | 606 | 0.300 |
Why?
|
| Signal Transduction | 6 | 2021 | 4505 | 0.300 |
Why?
|
| Regression Analysis | 2 | 2008 | 755 | 0.300 |
Why?
|
| RNA Splicing Factors | 2 | 2018 | 49 | 0.290 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2008 | 138 | 0.290 |
Why?
|
| DNA Primers | 1 | 2008 | 667 | 0.290 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1421 | 0.290 |
Why?
|
| Nerve Degeneration | 2 | 2019 | 124 | 0.290 |
Why?
|
| DNA Transposable Elements | 2 | 2018 | 176 | 0.280 |
Why?
|
| Memory Disorders | 2 | 2020 | 234 | 0.280 |
Why?
|
| Hippocampus | 4 | 2020 | 805 | 0.270 |
Why?
|
| Transcription, Genetic | 4 | 2020 | 1696 | 0.270 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 460 | 0.260 |
Why?
|
| Drosophila | 5 | 2023 | 766 | 0.260 |
Why?
|
| Mutation | 10 | 2023 | 5738 | 0.250 |
Why?
|
| Female | 33 | 2024 | 64469 | 0.250 |
Why?
|
| Poisson Distribution | 2 | 2016 | 48 | 0.250 |
Why?
|
| Genetic Variation | 4 | 2019 | 1476 | 0.250 |
Why?
|
| Gene Knockdown Techniques | 5 | 2018 | 351 | 0.240 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 190 | 0.240 |
Why?
|
| Histones | 2 | 2018 | 522 | 0.240 |
Why?
|
| Intellectual Disability | 4 | 2020 | 1043 | 0.240 |
Why?
|
| Mice, Transgenic | 8 | 2022 | 2439 | 0.230 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2020 | 996 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 1889 | 0.220 |
Why?
|
| Seizures | 2 | 2020 | 873 | 0.220 |
Why?
|
| Cell Transdifferentiation | 1 | 2024 | 67 | 0.220 |
Why?
|
| Behavior, Animal | 4 | 2021 | 476 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 4334 | 0.220 |
Why?
|
| Nervous System Physiological Phenomena | 1 | 2023 | 17 | 0.210 |
Why?
|
| Neuroglia | 2 | 2023 | 191 | 0.210 |
Why?
|
| Histone Demethylases | 1 | 2023 | 38 | 0.210 |
Why?
|
| Spliceosomes | 2 | 2019 | 48 | 0.200 |
Why?
|
| Models, Biological | 6 | 2022 | 1435 | 0.200 |
Why?
|
| Protein Stability | 2 | 2021 | 166 | 0.200 |
Why?
|
| Microfilament Proteins | 3 | 2019 | 278 | 0.200 |
Why?
|
| Base Sequence | 5 | 2018 | 3116 | 0.200 |
Why?
|
| Chromatin | 2 | 2023 | 550 | 0.200 |
Why?
|
| Fibroblasts | 2 | 2024 | 874 | 0.200 |
Why?
|
| Haploinsufficiency | 2 | 2020 | 248 | 0.190 |
Why?
|
| Pleural Neoplasms | 3 | 2009 | 65 | 0.190 |
Why?
|
| Electrical Synapses | 1 | 2021 | 7 | 0.190 |
Why?
|
| Transcription Factors | 2 | 2022 | 2586 | 0.190 |
Why?
|
| Mesothelioma | 3 | 2009 | 80 | 0.190 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2021 | 37 | 0.190 |
Why?
|
| Huntingtin Protein | 1 | 2021 | 60 | 0.190 |
Why?
|
| Multiprotein Complexes | 1 | 2022 | 207 | 0.180 |
Why?
|
| Gene Ontology | 1 | 2020 | 47 | 0.180 |
Why?
|
| Cleavage And Polyadenylation Specificity Factor | 1 | 2020 | 15 | 0.180 |
Why?
|
| Brain Stem | 1 | 2021 | 118 | 0.180 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 2020 | 16 | 0.180 |
Why?
|
| 5' Untranslated Regions | 1 | 2020 | 60 | 0.180 |
Why?
|
| Neoplasms, Adipose Tissue | 1 | 2020 | 8 | 0.180 |
Why?
|
| Transcription Factors, General | 1 | 2020 | 8 | 0.180 |
Why?
|
| Neoplasm Metastasis | 2 | 2021 | 651 | 0.170 |
Why?
|
| COUP Transcription Factor I | 1 | 2020 | 91 | 0.170 |
Why?
|
| Interferon-beta | 1 | 2020 | 50 | 0.170 |
Why?
|
| RNA, Messenger | 4 | 2021 | 2827 | 0.170 |
Why?
|
| Genome | 3 | 2018 | 472 | 0.170 |
Why?
|
| Abdominal Neoplasms | 1 | 2020 | 33 | 0.170 |
Why?
|
| Male | 25 | 2024 | 59115 | 0.170 |
Why?
|
| Metabolomics | 2 | 2023 | 389 | 0.170 |
Why?
|
| Bone Neoplasms | 2 | 2021 | 424 | 0.170 |
Why?
|
| Amyloid | 1 | 2020 | 64 | 0.170 |
Why?
|
| Cells, Cultured | 7 | 2021 | 3070 | 0.170 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2019 | 28 | 0.170 |
Why?
|
| Adaptation, Physiological | 1 | 2021 | 263 | 0.170 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2022 | 221 | 0.170 |
Why?
|
| Reference Standards | 1 | 2020 | 240 | 0.170 |
Why?
|
| Syndrome | 2 | 2020 | 1118 | 0.160 |
Why?
|
| Interneurons | 1 | 2020 | 135 | 0.160 |
Why?
|
| Chromosome Disorders | 2 | 2019 | 311 | 0.160 |
Why?
|
| Bone and Bones | 1 | 2021 | 262 | 0.160 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2019 | 15 | 0.160 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2019 | 37 | 0.160 |
Why?
|
| Complement C3a | 1 | 2018 | 20 | 0.160 |
Why?
|
| RNA, Nuclear | 1 | 2018 | 4 | 0.160 |
Why?
|
| Genetic Association Studies | 2 | 2020 | 756 | 0.160 |
Why?
|
| Nuclear Receptor Co-Repressor 1 | 1 | 2019 | 54 | 0.160 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2018 | 135 | 0.160 |
Why?
|
| Synaptic Transmission | 1 | 2021 | 348 | 0.160 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 125 | 0.160 |
Why?
|
| Receptors, Complement | 1 | 2018 | 35 | 0.160 |
Why?
|
| Topotecan | 1 | 2018 | 49 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2019 | 111 | 0.160 |
Why?
|
| Genes | 1 | 2019 | 443 | 0.160 |
Why?
|
| Polycomb-Group Proteins | 1 | 2018 | 18 | 0.160 |
Why?
|
| Gene Targeting | 1 | 2019 | 177 | 0.160 |
Why?
|
| Hypoglycemia | 1 | 2020 | 191 | 0.150 |
Why?
|
| Meningioma | 1 | 2019 | 110 | 0.150 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2018 | 13 | 0.150 |
Why?
|
| Species Specificity | 3 | 2020 | 550 | 0.150 |
Why?
|
| Polymerase Chain Reaction | 5 | 2018 | 1592 | 0.150 |
Why?
|
| Mice, Knockout | 7 | 2022 | 3763 | 0.150 |
Why?
|
| Bias | 1 | 2018 | 113 | 0.150 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2020 | 263 | 0.150 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 140 | 0.150 |
Why?
|
| Meningeal Neoplasms | 1 | 2019 | 173 | 0.150 |
Why?
|
| Cell Line, Tumor | 6 | 2021 | 3288 | 0.150 |
Why?
|
| Inventions | 1 | 2017 | 17 | 0.150 |
Why?
|
| Alleles | 4 | 2024 | 1587 | 0.150 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 96 | 0.150 |
Why?
|
| Cell Line | 6 | 2021 | 2788 | 0.150 |
Why?
|
| Biomarkers | 4 | 2022 | 2920 | 0.150 |
Why?
|
| alpha-Synuclein | 1 | 2018 | 109 | 0.150 |
Why?
|
| Endopeptidases | 1 | 2018 | 115 | 0.150 |
Why?
|
| Receptors, Estrogen | 1 | 2021 | 789 | 0.140 |
Why?
|
| RNA-Binding Proteins | 2 | 2018 | 567 | 0.140 |
Why?
|
| Gain of Function Mutation | 1 | 2018 | 103 | 0.140 |
Why?
|
| Hypothalamus | 1 | 2019 | 213 | 0.140 |
Why?
|
| Longevity | 1 | 2018 | 120 | 0.140 |
Why?
|
| Gene Editing | 1 | 2019 | 177 | 0.140 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2018 | 85 | 0.140 |
Why?
|
| Hearing | 1 | 2016 | 51 | 0.140 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2018 | 172 | 0.140 |
Why?
|
| Computer Graphics | 1 | 2016 | 38 | 0.140 |
Why?
|
| Leiomyoma | 1 | 2017 | 90 | 0.140 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 145 | 0.140 |
Why?
|
| Hair Cells, Auditory | 1 | 2016 | 64 | 0.140 |
Why?
|
| Frontotemporal Dementia | 1 | 2016 | 37 | 0.140 |
Why?
|
| Cochlea | 1 | 2016 | 87 | 0.130 |
Why?
|
| Uterine Neoplasms | 1 | 2017 | 117 | 0.130 |
Why?
|
| HEK293 Cells | 4 | 2021 | 739 | 0.130 |
Why?
|
| Neurogenesis | 1 | 2018 | 194 | 0.130 |
Why?
|
| Genes, Duplicate | 1 | 2015 | 16 | 0.130 |
Why?
|
| Protein Isoforms | 1 | 2017 | 408 | 0.130 |
Why?
|
| Astrocytes | 1 | 2018 | 242 | 0.130 |
Why?
|
| Memory | 1 | 2019 | 355 | 0.130 |
Why?
|
| Cognition Disorders | 2 | 2018 | 551 | 0.130 |
Why?
|
| Epilepsy | 2 | 2020 | 847 | 0.130 |
Why?
|
| Machine Learning | 1 | 2017 | 203 | 0.120 |
Why?
|
| Nuclear Proteins | 2 | 2022 | 1281 | 0.120 |
Why?
|
| Receptors, Notch | 1 | 2016 | 205 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2019 | 523 | 0.120 |
Why?
|
| Progesterone | 1 | 2017 | 624 | 0.120 |
Why?
|
| Nuclear Matrix | 2 | 2005 | 26 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2019 | 835 | 0.120 |
Why?
|
| Software Design | 1 | 2014 | 23 | 0.120 |
Why?
|
| Inheritance Patterns | 1 | 2014 | 124 | 0.120 |
Why?
|
| Neurodegenerative Diseases | 1 | 2017 | 251 | 0.110 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 2007 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2017 | 559 | 0.110 |
Why?
|
| Gene Dosage | 1 | 2015 | 441 | 0.110 |
Why?
|
| YY1 Transcription Factor | 1 | 2013 | 12 | 0.110 |
Why?
|
| Serine | 1 | 2014 | 174 | 0.110 |
Why?
|
| Oxidation-Reduction | 1 | 2014 | 442 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2019 | 1115 | 0.110 |
Why?
|
| Disease | 1 | 2014 | 129 | 0.110 |
Why?
|
| Drug Combinations | 1 | 2014 | 263 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 369 | 0.110 |
Why?
|
| Deep Brain Stimulation | 1 | 2018 | 382 | 0.110 |
Why?
|
| Cytokines | 1 | 2018 | 1274 | 0.110 |
Why?
|
| Hypoxia | 1 | 2014 | 246 | 0.100 |
Why?
|
| Trophoblasts | 1 | 2013 | 109 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 3066 | 0.100 |
Why?
|
| COUP Transcription Factor II | 1 | 2013 | 117 | 0.100 |
Why?
|
| Cerebellar Neoplasms | 1 | 2015 | 278 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3432 | 0.100 |
Why?
|
| Models, Genetic | 2 | 2013 | 748 | 0.100 |
Why?
|
| Prostatic Neoplasms | 1 | 2021 | 1515 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2015 | 630 | 0.100 |
Why?
|
| Medulloblastoma | 1 | 2015 | 333 | 0.100 |
Why?
|
| Depression | 1 | 2020 | 1205 | 0.100 |
Why?
|
| DNA Methylation | 2 | 2018 | 987 | 0.090 |
Why?
|
| Aging | 3 | 2023 | 1157 | 0.090 |
Why?
|
| Membrane Proteins | 1 | 2018 | 1524 | 0.090 |
Why?
|
| Gene Expression | 4 | 2020 | 1579 | 0.090 |
Why?
|
| Disease Progression | 4 | 2021 | 1970 | 0.090 |
Why?
|
| Ovary | 1 | 2013 | 390 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1284 | 0.090 |
Why?
|
| Cell Proliferation | 4 | 2021 | 2307 | 0.090 |
Why?
|
| Asbestos | 2 | 2009 | 14 | 0.090 |
Why?
|
| Protein Binding | 3 | 2022 | 1734 | 0.090 |
Why?
|
| Mitochondria | 1 | 2014 | 665 | 0.080 |
Why?
|
| Cluster Analysis | 2 | 2023 | 385 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 1676 | 0.080 |
Why?
|
| Gene Duplication | 2 | 2024 | 358 | 0.080 |
Why?
|
| Myxococcales | 1 | 2008 | 1 | 0.080 |
Why?
|
| Base Composition | 1 | 2008 | 72 | 0.080 |
Why?
|
| Neoplasm Proteins | 1 | 2013 | 670 | 0.080 |
Why?
|
| Logistic Models | 1 | 2013 | 1756 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2017 | 1710 | 0.080 |
Why?
|
| Purkinje Cells | 2 | 2022 | 156 | 0.080 |
Why?
|
| Mental Disorders | 1 | 2015 | 821 | 0.080 |
Why?
|
| Molecular Sequence Data | 4 | 2015 | 3870 | 0.080 |
Why?
|
| Open Reading Frames | 1 | 2008 | 211 | 0.080 |
Why?
|
| Genetic Testing | 1 | 2014 | 989 | 0.080 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2009 | 246 | 0.070 |
Why?
|
| Genome, Bacterial | 1 | 2008 | 184 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2009 | 329 | 0.070 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 467 | 0.070 |
Why?
|
| Dendritic Spines | 2 | 2018 | 54 | 0.070 |
Why?
|
| Up-Regulation | 2 | 2020 | 870 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 992 | 0.070 |
Why?
|
| Asbestosis | 1 | 2005 | 2 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2021 | 1612 | 0.070 |
Why?
|
| Sialoglycoproteins | 1 | 2005 | 49 | 0.060 |
Why?
|
| Proteins | 2 | 2023 | 1046 | 0.060 |
Why?
|
| Mammary Glands, Animal | 1 | 2008 | 482 | 0.060 |
Why?
|
| Heterografts | 2 | 2015 | 185 | 0.060 |
Why?
|
| Occupational Exposure | 1 | 2005 | 128 | 0.060 |
Why?
|
| Genetic Heterogeneity | 1 | 2024 | 123 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2017 | 1102 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2021 | 700 | 0.060 |
Why?
|
| Neoplasms | 2 | 2015 | 2749 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1199 | 0.060 |
Why?
|
| Locus Control Region | 1 | 2003 | 8 | 0.060 |
Why?
|
| Case-Control Studies | 2 | 2021 | 3223 | 0.060 |
Why?
|
| Globins | 1 | 2003 | 35 | 0.060 |
Why?
|
| Maternal Inheritance | 1 | 2023 | 13 | 0.050 |
Why?
|
| Growth Differentiation Factors | 1 | 2023 | 11 | 0.050 |
Why?
|
| Regulatory Factor X1 | 1 | 2022 | 7 | 0.050 |
Why?
|
| Ubiquitin-Specific Peptidase 7 | 1 | 2023 | 17 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2003 | 167 | 0.050 |
Why?
|
| Claudins | 1 | 2022 | 29 | 0.050 |
Why?
|
| K562 Cells | 2 | 2018 | 94 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 286 | 0.050 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2023 | 124 | 0.050 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 660 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 1357 | 0.050 |
Why?
|
| Electroencephalography | 2 | 2018 | 841 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2019 | 799 | 0.050 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2021 | 12 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2021 | 35 | 0.050 |
Why?
|
| Oocytes | 1 | 2023 | 291 | 0.050 |
Why?
|
| Clonal Evolution | 1 | 2021 | 38 | 0.050 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2021 | 55 | 0.050 |
Why?
|
| Rats | 2 | 2019 | 3654 | 0.050 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2021 | 80 | 0.050 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2021 | 98 | 0.050 |
Why?
|
| Locomotion | 1 | 2021 | 68 | 0.050 |
Why?
|
| Research Personnel | 1 | 2022 | 117 | 0.050 |
Why?
|
| Apoptosis | 2 | 2021 | 1788 | 0.050 |
Why?
|
| MCF-7 Cells | 1 | 2021 | 222 | 0.050 |
Why?
|
| Mice, Inbred NOD | 1 | 2021 | 285 | 0.040 |
Why?
|
| Computers | 1 | 2020 | 68 | 0.040 |
Why?
|
| Cell Communication | 1 | 2021 | 165 | 0.040 |
Why?
|
| Complement C3 | 1 | 2020 | 49 | 0.040 |
Why?
|
| Rare Diseases | 1 | 2022 | 185 | 0.040 |
Why?
|
| Cyclophosphamide | 1 | 2022 | 422 | 0.040 |
Why?
|
| Osteogenesis | 1 | 2021 | 153 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2021 | 384 | 0.040 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2019 | 17 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 391 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2021 | 571 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2021 | 697 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 517 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 505 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2021 | 1077 | 0.040 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 476 | 0.040 |
Why?
|
| Post-Synaptic Density | 1 | 2019 | 11 | 0.040 |
Why?
|
| Microglia | 1 | 2020 | 95 | 0.040 |
Why?
|
| Loss of Function Mutation | 1 | 2020 | 139 | 0.040 |
Why?
|
| Receptors, GABA-A | 1 | 2019 | 58 | 0.040 |
Why?
|
| Amino Acid Substitution | 1 | 2020 | 389 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2020 | 301 | 0.040 |
Why?
|
| Prosencephalon | 1 | 2018 | 40 | 0.040 |
Why?
|
| Macrophages | 1 | 2022 | 614 | 0.040 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2019 | 129 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 6100 | 0.040 |
Why?
|
| Fornix, Brain | 1 | 2018 | 18 | 0.040 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2021 | 873 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2018 | 140 | 0.040 |
Why?
|
| Argonaute Proteins | 1 | 2018 | 24 | 0.040 |
Why?
|
| Mice, 129 Strain | 1 | 2018 | 100 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2018 | 106 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2018 | 238 | 0.040 |
Why?
|
| Sequence Deletion | 1 | 2020 | 526 | 0.040 |
Why?
|
| Receptor, Notch1 | 1 | 2018 | 66 | 0.040 |
Why?
|
| Glycolysis | 1 | 2018 | 143 | 0.040 |
Why?
|
| Role | 1 | 2017 | 26 | 0.040 |
Why?
|
| Databases, Nucleic Acid | 1 | 2018 | 69 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2019 | 270 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2018 | 323 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2018 | 314 | 0.040 |
Why?
|
| Neural Pathways | 1 | 2019 | 262 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2018 | 159 | 0.040 |
Why?
|
| Gene Library | 1 | 2018 | 218 | 0.040 |
Why?
|
| Organ of Corti | 1 | 2016 | 26 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2019 | 617 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 231 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2024 | 13766 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2018 | 187 | 0.030 |
Why?
|
| Rats, Transgenic | 1 | 2016 | 16 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 2016 | 145 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 231 | 0.030 |
Why?
|
| Internet | 1 | 2019 | 372 | 0.030 |
Why?
|
| Ear, Inner | 1 | 2016 | 52 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2016 | 20 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 158 | 0.030 |
Why?
|
| Motor Activity | 1 | 2019 | 507 | 0.030 |
Why?
|
| Pedigree | 1 | 2020 | 1574 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2013 | 1460 | 0.030 |
Why?
|
| Attachment Sites, Microbiological | 1 | 2015 | 7 | 0.030 |
Why?
|
| Prognosis | 2 | 2019 | 4477 | 0.030 |
Why?
|
| Homozygote | 1 | 2018 | 535 | 0.030 |
Why?
|
| Adult | 3 | 2023 | 28621 | 0.030 |
Why?
|
| Luciferases | 1 | 2015 | 136 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2018 | 679 | 0.030 |
Why?
|
| Registries | 1 | 2022 | 1351 | 0.030 |
Why?
|
| Lentivirus | 1 | 2015 | 85 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2019 | 343 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 85 | 0.030 |
Why?
|
| Apolipoproteins E | 1 | 2016 | 188 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 512 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2017 | 598 | 0.030 |
Why?
|
| Interpersonal Relations | 1 | 2017 | 229 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2017 | 351 | 0.030 |
Why?
|
| Animals, Newborn | 1 | 2018 | 1004 | 0.030 |
Why?
|
| Glycine Hydroxymethyltransferase | 1 | 2014 | 6 | 0.030 |
Why?
|
| Phosphoglycerate Dehydrogenase | 1 | 2014 | 5 | 0.030 |
Why?
|
| Action Potentials | 1 | 2018 | 499 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 636 | 0.030 |
Why?
|
| Integrases | 1 | 2015 | 162 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 297 | 0.030 |
Why?
|
| Regeneration | 1 | 2016 | 200 | 0.030 |
Why?
|
| Genes, myc | 1 | 2014 | 99 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2014 | 100 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 1296 | 0.030 |
Why?
|
| Aged | 3 | 2019 | 18463 | 0.030 |
Why?
|
| Exons | 1 | 2016 | 794 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2014 | 228 | 0.030 |
Why?
|
| Genotype | 1 | 2020 | 2534 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2014 | 230 | 0.030 |
Why?
|
| X Chromosome | 1 | 2014 | 339 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 665 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1209 | 0.030 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 383 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 1393 | 0.030 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 171 | 0.030 |
Why?
|
| CpG Islands | 1 | 2013 | 321 | 0.030 |
Why?
|
| Genomic Imprinting | 1 | 2013 | 123 | 0.030 |
Why?
|
| Middle Aged | 3 | 2019 | 25390 | 0.030 |
Why?
|
| Cell Survival | 1 | 2014 | 818 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2013 | 297 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2013 | 347 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 2059 | 0.020 |
Why?
|
| Homeostasis | 1 | 2014 | 680 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 1291 | 0.020 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2009 | 7 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2009 | 49 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2013 | 1368 | 0.020 |
Why?
|
| Fetus | 1 | 2013 | 580 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2013 | 1360 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2009 | 654 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2013 | 898 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 751 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2009 | 608 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2009 | 865 | 0.020 |
Why?
|
| Risk Factors | 1 | 2020 | 9673 | 0.020 |
Why?
|
| Cell Movement | 1 | 2009 | 846 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 8709 | 0.020 |
Why?
|
| Osteopontin | 1 | 2005 | 50 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 2677 | 0.020 |
Why?
|
| Child | 1 | 2024 | 24035 | 0.010 |
Why?
|
| RNA, Complementary | 1 | 2004 | 4 | 0.010 |
Why?
|
| ROC Curve | 1 | 2005 | 550 | 0.010 |
Why?
|
| Time Factors | 2 | 2004 | 5997 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 808 | 0.010 |
Why?
|
| Actins | 1 | 2005 | 340 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2005 | 1225 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 1386 | 0.010 |
Why?
|